Marinus’ clinical trial of ganaxolone fails to meet primary endpoint
In response to the findings, Marinus is halting further clinical development of ganaxolone.
25 October 2024
25 October 2024
In response to the findings, Marinus is halting further clinical development of ganaxolone.
Merging industry-leading business intelligence & award-winning journalism, this is an unrivalled opportunity for engagement with B2B professionals across a network of 40+ leading media websites.
Steer your business strategy with key data and insights from our latest market research reports and company profiles. Not ready to buy? Start small by downloading a sample report first.
Give your business an edge with our leading industry insights.